(Vienna, 25 February 2019) The care of patients with chronic diseases could be improved by regular telemonitoring. This is the finding of a recent study conducted by...

Pharma industry validates shared vision, strong neuroscience interest, and greater operational scale as robust results illustrate greater than 20% increase in new cl...

AstraZeneca's targeted cancer therapy Lynparza met the primary endpoint of a Phase 3 study testing the drug as a first-line maintenance treatment for a subset of pan...

The Phase III THEMIS trial met its primary endpoint and demonstrated that Brilinta (ticagrelor), taken in conjunction with aspirin, showed a statistically-significa...

A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged...

Early intensive therapy for multiple sclerosis leads to better long-term outcomes, despite being perceived as high risk  New findings by researchers at Cardiff Uni...

First commercial program under Bavarian Nordic and Janssen Vaccines & Prevention B.V. collaboration advancing into clinical trialsA therapeutic vaccine may repre...

Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academi...

FRAMES trial expected to initiate patient recruitment in upcoming weeks in Spain, Belgium and other European countriesProfessor Alexandra Durr, principal investigato...